特定康复方案对帕金森病肌肉质量和功能的影响:多中心前性研究
Alessandro de Sire1,2,3, Nicola Marotta2,4, Emanuele Prestifilippo1
1Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Disability and rehabilitation
|October 27, 2025
概括
这项研究表明,有针对性的康复计划显著改善了帕金森病 (PD) 患者的肌肉质量,力量和身体功能. 这种干预的好处随着时间的推移而持续,减少了残疾.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 物理疗法物理治疗
背景情况:
- 标志着肌肉质量和力量的损失的萨尔科佩尼亚在帕金森病 (PD) 中很普遍.
- 这种情况加剧了残疾,并影响了PD患者的生活质量.
- 早期识别和干预对于管理PD肌肉骨衰退至关重要.
研究的目的:
- 调查针对帕金森病患者的 Sarcopenia 的目标康复计划的有效性.
- 评估肌肉质量,力量和身体表现的改善.
- 评估康复对减少PD残疾的长期影响.
主要方法:
- 一项多中心前性研究,涉及61名成年人 (50-80岁) 在5年内被诊断患有PD.
- 测量的主要结果包括尾骨肌肉质量 (ASM),手握强度 (HGS) 和短物理性能电池 (SPPB) 评分.
- 患者接受了一项标准化的理疗计划,并建议继续进行家庭炼.
主要成果:
- 在康复后的ASM (p < 0.001) 和SPPB (p < 0.001) 中观察到显著的改善.
- 观察到改善HGS的趋势 (p = 0.081) 和显著减少肉患者的数量 (p < 0.001).
- 这些积极的结果,包括减少了肉症,在随访期间保持不变.
结论:
- 有针对性的康复治疗是治疗帕金森病中肉症的安全有效策略.
- 该计划导致关键肌肉骨和功能参数的可衡量的改善.
- 需要进行进一步的研究,延长后续期,以充分了解长期影响.
关键词:
帕金森病是帕金森氏症的一种疾病.萨尔科佩尼亚是什么意思 萨尔科佩尼亚生物阻抗分析分析肌肉质量 肌肉质量 肌肉质量肌肉的力量 肌肉的力量 肌肉的力量业绩表现表现的表现表现是什么物理治疗疗法 物理治疗更多相关视频
05:28Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
1.1K
09:19Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
26.2K
相关概念视频
Parkinson's Disease: Treatment
970
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
970
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
